Skip to content

FOR ELEVATED SCIENCE, IMPROVED DISEASE MANAGEMENT, AND PATIENT CARE

By combining advanced EIS technology and AI we enable earlier, more accurate diagnosis of skin conditions — improving patient outcomes.

Trusted by leading clinics

Nevisense supports dermatologists and researchers worldwide in enhanced patient care and data-driven frontline research.
fictional-clinic-logos-blue (1)-1

Non-invasive skin diagnostics

Nevisense delivers objective, non-invasive skin assessment technology—supporting early detection of skin cancer, and advancing dermatological research worldwide.

IMG_0805

MELANOMA DETECTION

Our unique technology supporting clinicians in melanoma management.

See clinical applications
254A9875-1-1

SKIN BARRIER
ASSESSMENT

Nevisense supports researchers and product developers worldwide.

Learn about research use

Trusted by experts. Chosen for results.

"Nevisense has become an essential part of my workflow. It gives me the confidence I need in my every day practice". 
Clinican testimonial
Nevisense platform

Nevisense

Our state-of-the-art system combines EIS and AI for early skin cancer detection.

Read more
sci-navisense-go-tool

Nevisense Go

A portable, wireless version – supporting front-line research, bringing Nevisense even closer.

Read more
NEVISENSE FOR PATIENTS

More than 500,000 patient examinations worldwide

Nevisense helps clinicians detect what can't be seen by visual examination alone - supporting early detection and better patient outcomes.

Read more
nevisense-patient-mosaic-web (2)
OUR TECHNOLOGY

Objective insights.
Better outcomes. 

Nevisense uses AI-powered EIS imaging to reveal subsurface skin structures, enabling early detection of skin cancer and advancing skin barrier research. 

IMG_1099
90+
Clinical Studies
FDACE +
Approved
35+
Countries
”Nevisense has changes the way I evaluate atypical lesions”
- Dr. Sophie Klockhoff

Scientifically validated, globally trusted

Nevisense is backed by over three decades of research, clinical experience and a large amount of scientific publications. With 300,000+ patients evaluated worldwide and more than 500 clinics using Nevisense for skin cancer detection, it is a trusted tool for dermatologists, academic researchers, and product developers.

Innovation with a purpose

SciBase is a Swedish medtech company driven by a single goal: to improve skin health through smarter diagnostics. With our unique combination of EIS and AI, we lead the way in non-invasive solutions for clinicians and researchers worldwide.

Sign up to our newsletter

Sign up for the SciBase newsletter to stay up to date with the latest innovations in skin diagnostics, clinical insights and company news. Get expert perspectives, product updates, and research highlights delivered directly to your inbox.